Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Robert Bissonnette
Introduction
Robert Bissonnette is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of dermatology, particularly in the treatment of psoriasis. His innovative approach combines diagnostic methods with therapeutic applications, showcasing the potential of endogenous porphyrins in skin treatment.
Latest Patents
Bissonnette holds a patent for the "Photoactivation of endogenous porphyrins for treatment of psoriasis." This invention provides a diagnostic method for identifying psoriatic plaques by detecting elevated levels of porphyrins, specifically protoporphyrin IX, compared to normal skin and skin affected by other dermatological conditions. The method utilizes fluorescence and spectral analysis to identify psoriatic plaques with elevated porphyrin levels. Furthermore, the invention outlines a treatment approach where visible light activates endogenous porphyrins in these plaques, potentially leading to effective treatment outcomes.
Career Highlights
Robert Bissonnette is affiliated with the University of British Columbia, where he continues to advance research in dermatological treatments. His work emphasizes the importance of optimizing skin conditions to enhance the concentration of endogenous porphyrins in psoriatic plaques. This innovative approach not only addresses the symptoms of psoriasis but also aims to improve the overall quality of life for patients suffering from this condition.
Collaborations
Bissonnette collaborates with esteemed colleagues such as Harvey Lui and Calum Macaulay. Their combined expertise contributes to the ongoing research and development of effective treatments for skin conditions, particularly psoriasis.
Conclusion
Robert Bissonnette's contributions to the field of dermatology through his innovative patent demonstrate the potential of utilizing endogenous porphyrins for treating psoriasis. His work at the University of British Columbia and collaborations with fellow researchers highlight the importance of continued innovation in medical treatments.